Floatz logo

Isis 3521

Melanoma (Skin)

European Organisation for Research and Treatment of Cancer - EORTCPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
81/ 100

Competitive context

152 Active assets in the Melanoma (Skin) cohort.

Asset / SponsorPhaseRating
Alpha-Interferon
MIPO Clinic
Phase 3BBB
TIL
City of Hope Medical Center
Phase 2BBB
DACARBAZINE
Linnaeus Therapeutics, Inc.
Phase 3BBB
CIS-DIAMMINEDICHLOROPLATINUM II
MIPO Clinic
Phase 3BBB
Tyrosinase Peptide
University of Southern California
Phase 3BBB

View all 50 →

Same molecule, other indications

Isis 3521 is also rated in:

lung cancerDormant
B
Indicative ·
59 / 100
View asset →
breast cancerDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →